Health-care companies rose amid deal activity. Biomarin Pharmaceutical agreed to buy fellow biotechnology company Amicus Therapeutics for about $4.8 billion. Amicus founder and longtime leader, John ...
Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Nine more drug companies cut deals with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback